{
    "2019-03-28": [
        [
            {
                "time": "2018-03-05",
                "original_text": "AbbVie's big acquisition blowup: A one-off or an omen?",
                "features": {
                    "keywords": [
                        "acquisition",
                        "blowup",
                        "one-off",
                        "omen"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Analysts Have Mixed Opinions on AbbVie in March",
                "features": {
                    "keywords": [
                        "analysts",
                        "mixed opinions",
                        "March"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Drug giant cutting 178 jobs, three years after buying Peninsula biotech for $6 billion",
                "features": {
                    "keywords": [
                        "cutting jobs",
                        "Peninsula biotech",
                        "$6 billion"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-20",
                "original_text": "Real Estate Deals of the Year: AbbVie lease",
                "features": {
                    "keywords": [
                        "real estate",
                        "deals",
                        "lease"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}